,线

Xinyuan Huang1, Qingbo Li1, Manhong Xu1

  • 1Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, PR China, No.251 Fu Kang Road, Nankai District, Tianjin, 300384, PR China.

PubMed
概括

对于增殖性玻璃色素变异症 (PVR) 的类固醇治疗在早期可能更有效. 这项研究将PVR与代谢变化和线粒体功能障碍联系起来,这表明时间对德克萨米他的有效性至关重要.